Different outcomes for relapsed vs. refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)

Por Zhou, Margaret J., Doral, Michelle Y., DuBois, Steven G., Villablanca, Judith G., Yanik, Gregory A., Matthay, Katherine K.
Publicado no Eur J Cancer (2015)

Peripheral Blood Stem Cell Support for Multiple Cycles of Dose Intensive Induction Therapy is Feasible with Little Risk of Tumor Contamination in Advanced Stage Neuroblastoma; A Re...

Por Bensimhon, Pamela, Villablanca, Judith G., Sender, Leonard S., Matthay, Katherine K., Park, Julie R., Seeger, Robert, London, Wendy B., Yap, John Stephen F., Kreissman, Susan G.
Publicado em 2010

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Stu...

Por Matthay, Katherine K., Reynolds, C. Patrick, Seeger, Robert C., Shimada, Hiroyuki, Adkins, E. Stanton, Haas-Kogan, Daphne, Gerbing, Robert B., London, Wendy B., Villablanca, Judith G.
Publicado em 2009

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [(18)F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relap...

Por Taggart, Denah R., Han, Myo M., Quach, Alekist, Groshen, Susan, Ye, Wei, Villablanca, Judith G., Jackson, Hollie A., Mari Aparici, Carina, Carlson, David, Maris, John, Hawkins, Randall, Matthay, Katherine K.
Publicado em 2009

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study

Por Kang, Min H, Villablanca, Judith G, Glade Bender, Julia L, Matthay, Katherine K, Groshen, Susan, Sposto, Richard, Czarnecki, Scarlett, Ames, Matthew M, Reynolds, C Patrick, Marachelian, Araz, Maurer, Barry J
Publicado em 2014

Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

Por Matthay, Katherine K., Quach, Alekist, Huberty, John, Franc, Benjamin L., Hawkins, Randall A., Jackson, Hollie, Groshen, Susan, Shusterman, Suzanne, Yanik, Gregory, Veatch, Janet, Brophy, Patricia, Villablanca, Judith G., Maris, John M.
Publicado em 2009

Outcome of High-Risk Stage 3 Neuroblastoma with Myeloablative Therapy and 13-cis-Retinoic Acid: A Report from the Children’s Oncology Group

Por Park, Julie R., Villablanca, Judith G., London, Wendy B., Gerbing, Robert B., Haas-Kogan, Daphne, Stanton Adkins, E., Attiyeh, Edward F., Maris, John M., Seeger, Robert C., Patrick Reynolds, C., Matthay, Katherine K.
Publicado em 2009

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

Por Minturn, Jane E., Evans, Audrey E., Villablanca, Judith G., Yanik, Gregory A., Park, Julie R., Shusterman, Suzanne, Groshen, Susan, Hellriegel, Edward T., Bensen-Kennedy, Debra, Matthay, Katherine K., Brodeur, Garrett M., Maris, John M.
Publicado no Cancer Chemother Pharmacol (2011)

Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study

Por Wagner, Lars M., Villablanca, Judith G., Stewart, Clinton F., Crews, Kristine R., Groshen, Susan, Reynolds, C. Patrick, Park, Julie R., Maris, John M., Hawkins, Randall A., Daldrup-Link, Heike E., Jackson, Hollie A., Matthay, Katherine K.
Publicado em 2009

Thyroid and Hepatic Function After High Dose (131)I-Metaiodobenzylguanidine ((131)I-MIBG) Therapy for Neuroblastoma

Por Quach, Alekist, Ji, Lingyun, Mishra, Vikash, Sznewajs, Aimee, Veatch, Janet, Huberty, John, Franc, Benjamin, Sposto, Richard, Groshen, Susan, Wei, Denice, Fitzgerald, Paul, Maris, John M., Yanik, Gregory, Hawkins, Randall A., Villablanca, Judith G., Matthay, Katherine K.
Publicado em 2010

Phase I Trial of Fenretinide Delivered Orally in a Novel Organized Lipid Complex in Patients with Relapsed/Refractory Neuroblastoma: A Report from the New Approaches to Neuroblasto...

Por Maurer, Barry J., Kang, Min H., Janeba, Jitka, Villablanca, Judith G., Groshen, Susan, Matthay, Katherine K., Sondel, Paul M., Maris, John M., Jackson, Hollie A., Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Hasenauer, Beth, Reynolds, C. Patrick, Marachelian, Araz
Publicado em 2013

A Phase I Study of Zoledronic Acid and Low Dose Cyclophosphamide in Recurrent/Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) Study

Por Russell, Heidi V., Groshen, Susan G., Ara, Tasnim, DeClerck, Yves A., Hawkins, Randy, Jackson, Hollie A., Daldrup-Link, Heike E., Marachelian, Araz, Skerjanec, Andrej, Park, Julie R., Katzenstein, Howard, Matthay, Katherine K., Blaney, Susan M., Villablanca, Judith G.
Publicado em 2010

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

Por Asgharzadeh, Shahab, Salo, Jill A., Ji, Lingyun, Oberthuer, André, Fischer, Matthias, Berthold, Frank, Hadjidaniel, Michael, Liu, Cathy Wei-Yao, Metelitsa, Leonid S., Pique-Regi, Roger, Wakamatsu, Peter, Villablanca, Judith G., Kreissman, Susan G., Matthay, Katherine K., Shimada, Hiroyuki, London, Wendy B., Sposto, Richard, Seeger, Robert C.
Publicado em 2012

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: A report from the Children’s Oncolog...

Por Villablanca, Judith G., London, Wendy B., Naranjo, Arlene, McGrady, Patrick, Ames, Matthew M., Reid, Joel M., McGovern, Renee M., Buhrow, Sarah A., Jackson, Hollie, Stranzinger, Enno, Kitchen, Brenda J., Sondel, Paul M., Parisi, Marguerite T., Shulkin, Barry, Yanik, Gregory A., Cohn, Susan L., Reynolds, C. Patrick
Publicado em 2011

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

Por Kreissman, Susan G, Seeger, Robert C, Matthay, Katherine K, London, Wendy B, Sposto, Richard, Grupp, Stephan A, Haas-Kogan, Daphne A, LaQuaglia, Michael P, Yu, Alice, Diller, Lisa, Buxton, Allen, Park, Julie R, Cohn, Susan L, Maris, John M, Reynolds, C Patrick, Villablanca, Judith G
Publicado em 2013

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Por Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, London, Wendy B., Kreissman, Susan G., Chen, Helen X., Smith, Malcolm, Anderson, Barry, Villablanca, Judith G., Matthay, Katherine K., Shimada, Hiro, Grupp, Stephan A., Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A., Gillies, Steven D., Cohn, Susan L., Maris, John M., Sondel, Paul M.
Publicado em 2010

Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

Por DuBois, Steven G., Groshen, Susan, Park, Julie R., Haas-Kogan, Daphne A., Yang, Xiaodong, Geier, Ethan, Chen, Eugene, Giacomini, Kathy, Weiss, Brian, Cohn, Susan L., Granger, M. Meaghan, Yanik, Gregory A., Hawkins, Randall, Courtier, Jesse, Jackson, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Villablanca, Judith G., Marachelian, Araz, Matthay, Katherine K.
Publicado no Clin Cancer Res (2015)